Rocket


News + Filings
Transactions
Holdings





All
13F
13D/G
Other



ORBIMED CAPITAL LLC Create: Alert

All | News | Filings
Date FiledTypeDescription
05/24/2023 4 ORBIMED ADVISORS LLC (10% Owner) has filed a Form 4 on Prelude Therapeutics Inc
Txns: Bought 869,565 shares @ $5.75, valued at $5M
05/08/2023 4 ORBIMED ADVISORS LLC (10% Owner) has filed a Form 4 on Kinnate Biopharma Inc.
Txns: Bought 83,459 shares @ $2.75, valued at $229.5k
Bought 312,991 shares @ $2.75, valued at $860.7k
Bought 83,459 shares @ $2.75, valued at $229.5k
Bought 490,512 shares @ $2.82, valued at $1.4M
Bought 490,511 shares @ $2.82, valued at $1.4M
05/02/2023 4 ORBIMED ADVISORS LLC (10% Owner) has filed a Form 4 on Kinnate Biopharma Inc.
Txns: Bought 60,998 shares @ $2.55, valued at $155.5k
Bought 228,754 shares @ $2.55, valued at $583.3k
Bought 60,997 shares @ $2.55, valued at $155.5k
Bought 124,544 shares @ $2.62, valued at $326.3k
Bought 467,068 shares @ $2.62, valued at $1.2M
Bought 124,545 shares @ $2.62, valued at $326.3k
Bought 58,826 shares @ $2.67, valued at $157.1k
Bought 220,610 shares @ $2.67, valued at $589k
Bought 58,826 shares @ $2.67, valued at $157.1k
02/23/2023 4 ORBIMED ADVISORS LLC (10% Owner) has filed a Form 4 on Kinnate Biopharma Inc.
Txns: Granted 550,000 shares @ $0
Granted 550,000 shares @ $0
07/01/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/28/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/08/2022 4 ORBIMED ADVISORS LLC (10% Owner) has filed a Form 4 on Arcutis Biotherapeutics, Inc.
Txns: Sold 162,000 shares @ $20.69, valued at $3.4M
Sold 171,204 shares @ $20.69, valued at $3.5M
Sold 167,800 shares @ $20.66, valued at $3.5M
Sold 177,196 shares @ $20.66, valued at $3.7M
Sold 97,200 shares @ $20.71, valued at $2M
Sold 102,800 shares @ $20.71, valued at $2.1M
03/31/2022 4 ORBIMED ADVISORS LLC (10% Owner) has filed a Form 4 on PMV Pharmaceuticals, Inc.
Txns: Sold 365,000 shares @ $21.52, valued at $7.9M
Sold 75,000 shares @ $22.39, valued at $1.7M
Sold 34,500 shares @ $21.17, valued at $730.4k
02/15/2022 4 ORBIMED ADVISORS LLC (Director) has filed a Form 4 on Kinnate Biopharma Inc.
Txns: Bought 156,000 shares @ $10.22, valued at $1.6M
Bought 20,700 shares @ $9.98, valued at $206.6k
Bought 10,000 shares @ $9.89, valued at $98.9k
Bought 9,000 shares @ $9.96, valued at $89.6k
01/28/2022 4 ORBIMED ADVISORS LLC (10% Owner) has filed a Form 4 on Sierra Oncology, Inc.
Txns: Exercised (in-or-at-the-money) 374,962 options to buy @ $13.2, valued at $4.9M
Exercised (in-or-at-the-money) 56,244 options to buy @ $13.2, valued at $742.4k
Exercised (in-or-at-the-money) 56,244 options to buy @ $13.2, valued at $742.4k
09/08/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/02/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/30/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/25/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/19/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/16/2021 4 ORBIMED ADVISORS LLC (10% Owner) has filed a Form 4 on IMARA Inc.
Txns: Bought 1,666,666 shares @ $6, valued at $10M
02/19/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/12/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/09/2020 4 ORBIMED ADVISORS LLC (10% Owner) has filed a Form 4 on Kinnate Biopharma Inc.
Txns: Converted 243,494 shares @ $0
Converted 2,651,042 shares @ $0
Converted 118,794 shares @ $0
Converted 50,501 shares @ $0
Converted 9,461 shares @ $0
Converted 24,637 shares @ $0
Converted 243,494 preferred shares @ $0
Converted 2,651,042 preferred shares @ $0
Converted 118,398 preferred shares @ $0
Converted 50,501 preferred shares @ $0
Converted 9,461 preferred shares @ $0
12/08/2020 4 ORBIMED ADVISORS LLC (10% Owner) has filed a Form 4 on Silverback Therapeutics, Inc.
Txns: Bought 238,100 shares @ $21, valued at $5M
Converted 3,462,737 shares @ $0
Converted 2,493,741 shares @ $0
Converted 1,055,287 shares @ $0
Bought 952,377 shares @ $21, valued at $20M
Converted 12,857,142 preferred shares @ $0
Converted 9,259,259 preferred shares @ $0
Converted 3,918,279 preferred shares @ $0
12/04/2020 4 ORBIMED ADVISORS LLC (10% Owner) has filed a Form 4 on Kinnate Biopharma Inc.
Txns: Bought 300,000 shares @ $20, valued at $6M
Bought 450,000 shares @ $20, valued at $9M
10/06/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/29/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/29/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/02/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/25/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/04/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/04/2020 4 ORBIMED ADVISORS LLC (10% Owner) has filed a Form 4 on Arcutis Biotherapeutics, Inc.
Txns: Bought 382,388 shares @ $17, valued at $6.5M
Bought 176,500 shares @ $17, valued at $3M
Converted 2,825,603 shares @ $0
Converted 859,573 shares @ $0
Converted 429,786 shares @ $0
Converted 2,825,603 preferred shares @ $0
Converted 859,573 preferred shares @ $0
Converted 429,786 preferred shares @ $0
01/31/2020 4 ORBIMED ADVISORS LLC (10% Owner) has filed a Form 4 on Sierra Oncology, Inc.
Txns: Converted 1,477,320 shares @ $0
Converted 19,500 options to buy @ $0
01/13/2020 4 ORBIMED ADVISORS LLC (10% Owner) has filed a Form 4 on Alector, Inc.
Txns: Sold 286,787 shares @ $19.5, valued at $5.6M
Sold 91,818 shares @ $19.5, valued at $1.8M
Sold 1,392 shares @ $19.5, valued at $27.1k
12/26/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/19/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/09/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/11/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy